Tempus AI, Inc. reported $1.43B of revenue over the trailing twelve months, +50% on the year before. 8 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.43B (to Q2 2026). Net income: −$254M, trailing twelve months to Q2 2026. Free cash flow: −$263M, trailing twelve months to Q2 2026. Operating margin: −20%, trailing twelve months to Q2 2026.

TEMTempus AI, Inc.

Healthcare

$70.98-20% 1Y

$70.98

$42.3752 weeks$103.25

TEM as reported

Tempus AI, Inc. reported $1.43B of revenue over the trailing twelve months, +50% on the year before. 8 reported series are charted on this page, each one as filed.

$1.43B

Revenue, trailing twelve months · to Q2 2026 · +50% against the twelve months before

Net income: −$254M
Net income · +27% year on year · trailing twelve months to Q2 2026
Free cash flow: −$263M
Free cash flow · +278% year on year · trailing twelve months to Q2 2026
Operating margin: −20%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for TEM, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.43B	+50%	Q2 2026
Net income	−$254M	+27%	Q2 2026
EPS	−$1.45	+383%	Q2 2026
Operating margin	−20%	n/a	Q2 2026
Net margin	−18%	n/a	Q2 2026
ROE	−55%	n/a	Q2 2026
ROA	−11%	n/a	Q2 2026
Free cash flow	−$263M	+278%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.